| abstract |
This invention is related to new histone deacetylase inhibitors according to the general formula (I) wherein: the dotted line is an optional additional bond; R 1 is hydrogen, halogen, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 haloalkyl or C 1 C 6 haloalkoxy; R 2 , R 3 are, independently, hydrogen; C 1 -C 6 alkyl; aryl; or taken together with the carbon atoms to which they are bound form a bridged bicyclic ring or a fused heterocycle; X is CH or nitrogen; Y is a bond, oxygen, (CH 2 ) m CR 4 R 5 (CH 2 ) n , or (CH 2 ) o NR 6 (CH 2 ) p ; m, n, o, p, R 4 , R 5 and R 6 are as further defined in the specification; and pharmaceutical acceptable salts thereof. |